{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:57:21Z","timestamp":1793087841522,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100302"],"award-info":[{"award-number":["82100302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2023JH2\/20200037"],"award-info":[{"award-number":["2023JH2\/20200037"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02738-0","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T09:59:30Z","timestamp":1747043970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Mingzhi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuliang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"10431","key":"2738_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","volume":"403","author":"P Campbell","year":"2024","unstructured":"Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC. Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet. 2024;403(10431):1083\u201392.","journal-title":"Lancet"},{"issue":"6","key":"2738_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.122.062874","volume":"147","author":"F Capone","year":"2023","unstructured":"Capone F, Vettor R, Schiattarella GG. Cardiometabolic HFpEF: NASH of the heart. Circulation. 2023;147(6):451\u20133.","journal-title":"Circulation"},{"issue":"11","key":"2738_CR3","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124(11):1598\u2013617.","journal-title":"Circ Res"},{"issue":"18","key":"2738_CR4","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1161\/CIRCULATIONAHA.122.061481","volume":"146","author":"L Zhang","year":"2022","unstructured":"Zhang L, Cunningham JW, Claggett BL, Jacob J, Mendelson MM, Serrano-Fernandez P, Kaiser S, Yates DP, Healey M, Chen CW, et al. Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction. Circulation. 2022;146(18):1411\u20134.","journal-title":"Circulation"},{"issue":"9","key":"2738_CR5","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/s41591-022-01971-4","volume":"28","author":"PS Jhund","year":"2022","unstructured":"Jhund PS, Kondo T, Butt JH, Docherty KF, Claggett BL, Desai AS, Vaduganathan M, Gasparyan SB, Bengtsson O, Lindholm D, et al. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER. Nat Med. 2022;28(9):1956\u201364.","journal-title":"Nat Med"},{"issue":"20","key":"2738_CR6","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.124.069732","volume":"150","author":"N Gopalasingam","year":"2024","unstructured":"Gopalasingam N, Berg-Hansen K, Christensen KH, Ladefoged BT, Poulsen SH, Andersen MJ, Borlaug BA, Nielsen R, M\u00f8ller N, Wiggers H. Randomized crossover trial of 2-week ketone ester treatment in patients with type 2 diabetes and heart failure with preserved ejection fraction. Circulation. 2024;150(20):1570\u201383.","journal-title":"Circulation"},{"issue":"3","key":"2738_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jchf.2024.11.007","volume":"13","author":"S Patel","year":"2025","unstructured":"Patel S, Raman VK, Faselis C, Fonarow GC, Lam PH, Ahmed AA, Heidenreich PA, Anker SD, Deedwania P, Morgan CJ, et al. Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF. JACC Heart Fail. 2025;13(3):467\u201379.","journal-title":"JACC Heart Fail"},{"issue":"8 Pt 1","key":"2738_CR8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jchf.2023.05.010","volume":"11","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Abildstr\u00f8m SZ, Borlaug BA, Butler J, Christensen L, Davies M, Hovingh KG, Kitzman DW, Lindegaard ML, M\u00f8ller DV, et al. Design and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF phenotype. JACC Heart Fail. 2023;11(8 Pt 1):1000\u201310.","journal-title":"JACC Heart Fail"},{"issue":"36","key":"2738_CR9","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1093\/eurheartj\/ehab499","volume":"42","author":"AM Jackson","year":"2021","unstructured":"Jackson AM, Jhund PS, Anand IS, D\u00fcngen HD, Lam CSP, Lefkowitz MP, Linssen G, Lund LH, Maggioni AP, Pfeffer MA, et al. Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. Eur Heart J. 2021;42(36):3741\u201352.","journal-title":"Eur Heart J"},{"issue":"18","key":"2738_CR10","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart Failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol. 2023;81(18):1810\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2738_CR11","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","volume":"128","author":"WJ Paulus","year":"2021","unstructured":"Paulus WJ, Zile MR. From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited. Circ Res. 2021;128(10):1451\u201367.","journal-title":"Circ Res"},{"key":"2738_CR12","doi-asserted-by":"publisher","first-page":"16835","DOI":"10.1161\/circ.148.suppl_1.16835","volume":"148","author":"V Lamberson","year":"2023","unstructured":"Lamberson V, Yang Y, Myhre PL, Dorbala P, Rasheed H, Buckley LF, Claggett B, De Marzio M, Glass K, Hoogeveen RC, et al. Abstract 16835: plasma proteomics and risk of incident HFpEF and HFrEF: the atherosclerosis risk in communities study. Circulation. 2023;148:16835\u201316835.","journal-title":"Circulation"},{"issue":"18","key":"2738_CR13","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1093\/cvr\/cvac166","volume":"118","author":"F Capone","year":"2023","unstructured":"Capone F, Sotomayor-Flores C, Bode D, Wang R, Rodolico D, Strocchi S, Schiattarella GG. Cardiac metabolism in HFpEF: from fuel to signalling. Cardiovasc Res. 2023;118(18):3556\u201375.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2738_CR14","first-page":"305","volume":"32","author":"EA Akwo","year":"2023","unstructured":"Akwo EA, Robinson-Cohen C. Mendelian randomization and the association of fibroblast growth factor-23 with heart failure with preserved ejection fraction. Curr Opin Nephrol Hypertens. 2023;32(4):305\u201312.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"47","key":"2738_CR15","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","volume":"44","author":"SC Larsson","year":"2023","unstructured":"Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023;44(47):4913\u201324.","journal-title":"Eur Heart J"},{"key":"2738_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.734400","volume":"8","author":"X Li","year":"2021","unstructured":"Li X, Peng S, Guan B, Chen S, Zhou G, Wei Y, Gong C, Xu J, Lu X, Zhang X, et al. Genetically determined inflammatory biomarkers and the risk of heart failure: a mendelian randomization study. Front Cardiovasc Med. 2021;8: 734400.","journal-title":"Front Cardiovasc Med"},{"issue":"7538","key":"2738_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"AE Locke","year":"2015","unstructured":"Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197\u2013206.","journal-title":"Nature"},{"issue":"1","key":"2738_CR18","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/s41467-018-04951-w","volume":"9","author":"A Xue","year":"2018","unstructured":"Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, Yengo L, Lloyd-Jones LR, Sidorenko J, Wu Y, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941.","journal-title":"Nat Commun"},{"issue":"9","key":"2738_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ng.2383","volume":"44","author":"AP Morris","year":"2012","unstructured":"Morris AP, Voight BF, Teslovich TM, Ferreira T, Segr\u00e8 AV, Steinthorsdottir V, Strawbridge RJ, Khan H, Grallert H, Mahajan A, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981\u201390.","journal-title":"Nat Genet"},{"issue":"3","key":"2738_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/ng.3768","volume":"49","author":"HR Warren","year":"2017","unstructured":"Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B, Ntalla I, Surendran P, Liu C, Cook JP, et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017;49(3):403\u201315.","journal-title":"Nat Genet"},{"key":"2738_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103592","volume":"72","author":"X Chen","year":"2021","unstructured":"Chen X, Kong J, Pan J, Huang K, Zhou W, Diao X, Cai J, Zheng J, Yang X, Xie W, et al. Kidney damage causally affects the brain cortical structure: a Mendelian randomization study. EBioMedicine. 2021;72:103592.","journal-title":"EBioMedicine"},{"issue":"11","key":"2738_CR22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/s41588-018-0248-z","volume":"50","author":"O Canela-Xandri","year":"2018","unstructured":"Canela-Xandri O, Rawlik K, Tenesa A. An atlas of genetic associations in UK Biobank. Nat Genet. 2018;50(11):1593\u20139.","journal-title":"Nat Genet"},{"key":"2738_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104964","volume":"100","author":"W Liu","year":"2024","unstructured":"Liu W, Yang C, Lei F, Huang X, Cai J, Chen S, She ZG, Li H. Major lipids and lipoprotein levels and risk of blood pressure elevation: a Mendelian randomisation study. EBioMedicine. 2024;100:104964.","journal-title":"EBioMedicine"},{"issue":"1","key":"2738_CR24","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1038\/s41467-022-35323-0","volume":"13","author":"J Joseph","year":"2022","unstructured":"Joseph J, Liu C, Hui Q, Aragam K, Wang Z, Charest B, Huffman JE, Keaton JM, Edwards TL, Demissie S, et al. Genetic architecture of heart failure with preserved versus reduced ejection fraction. Nat Commun. 2022;13(1):7753.","journal-title":"Nat Commun"},{"issue":"2","key":"2738_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1517\/phgs.4.2.209.22627","volume":"4","author":"H Hakonarson","year":"2003","unstructured":"Hakonarson H, Gulcher JR, Stefansson K. deCODE genetics Inc. Pharmacogenomics. 2003;4(2):209\u201315.","journal-title":"Pharmacogenomics"},{"issue":"12","key":"2738_CR26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712\u201321.","journal-title":"Nat Genet"},{"issue":"1","key":"2738_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, Cerani A, Liang KYH, Yoshiji S, Willett JDS, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023;55(1):44\u201353.","journal-title":"Nat Genet"},{"issue":"6220","key":"2738_CR28","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A, et al. Proteomics tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","journal-title":"Science"},{"issue":"D1","key":"2738_CR29","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","volume":"45","author":"N Rappaport","year":"2017","unstructured":"Rappaport N, Twik M, Plaschkes I, Nudel R, Iny Stein T, Levitt J, Gershoni M, Morrey CP, Safran M, Lancet D. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2017;45(D1):D877\u2013D887.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2738_CR30","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1007\/s00125-024-06282-6","volume":"67","author":"S Sharma","year":"2024","unstructured":"Sharma S, Dong Q, Haid M, Adam J, Bizzotto R, Fernandez-Tajes JJ, Jones AG, Tura A, Artati A, Prehn C, et al. Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study. Diabetologia. 2024;67(12):2804\u201318.","journal-title":"Diabetologia"},{"issue":"2","key":"2738_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/db21-0490","volume":"71","author":"NA Yousri","year":"2022","unstructured":"Yousri NA, Suhre K, Yassin E, Al-Shakaki A, Robay A, Elshafei M, Chidiac O, Hunt SC, Crystal RG, Fakhro KA. Metabolic and metabo-clinical signatures of type 2 diabetes, obesity, retinopathy, and dyslipidemia. Diabetes. 2022;71(2):184\u2013205.","journal-title":"Diabetes"},{"issue":"5","key":"2738_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J, Taylor AE, Davies NM, Howe LD. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36(5):465\u201378.","journal-title":"Eur J Epidemiol"},{"key":"2738_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, Hartwig FP, Kutalik Z, Holmes MV, Minelli C, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186.","journal-title":"Wellcome Open Res"},{"key":"2738_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155611","volume":"146","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Zhuang Z, Li Y, Xiao W, Song Z, Huang N, Wang W, Dong X, Jia J, Huang T. Blood phytosterols in relation to cardiovascular diseases and mediating effects of blood lipids and hematological traits: a Mendelian randomization analysis. Metabolism. 2023;146: 155611.","journal-title":"Metabolism"},{"issue":"1","key":"2738_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40168-024-01797-x","volume":"12","author":"K Luo","year":"2024","unstructured":"Luo K, Taryn A, Moon EH, Peters BA, Solomon SD, Daviglus ML, Kansal MM, Thyagarajan B, Gellman MD, Cai J, et al. Gut microbiota, blood metabolites, and left ventricular diastolic dysfunction in US Hispanics\/Latinos. Microbiome. 2024;12(1):85.","journal-title":"Microbiome"},{"key":"2738_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103284","volume":"66","author":"M Shuai","year":"2021","unstructured":"Shuai M, Zuo LS, Miao Z, Gou W, Xu F, Jiang Z, Ling CW, Fu Y, Xiong F, Chen YM, et al. Multi-omics analyses reveal relationships among dairy consumption, gut microbiota and cardiometabolic health. EBioMedicine. 2021;66:103284.","journal-title":"EBioMedicine"},{"issue":"1","key":"2738_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12933-016-0479-1","volume":"15","author":"Y Obata","year":"2016","unstructured":"Obata Y, Maeda N, Yamada Y, Yamamoto K, Nakamura S, Yamaoka M, Tanaka Y, Masuda S, Nagao H, Fukuda S, et al. Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects. Cardiovasc Diabetol. 2016;15(1):159.","journal-title":"Cardiovasc Diabetol"},{"issue":"16","key":"2738_CR38","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA. 2021;326(16):1614\u201321.","journal-title":"JAMA"},{"issue":"D1","key":"2738_CR39","doi-asserted-by":"publisher","first-page":"D730","DOI":"10.1093\/nar\/gkae1113","volume":"53","author":"D Szklarczyk","year":"2025","unstructured":"Szklarczyk D, Nastou K, Koutrouli M, Kirsch R, Mehryary F, Hachilif R, Hu D, Peluso ME, Huang Q, Fang T, et al. The STRING database in 2025: protein networks with directionality of regulation. Nucleic Acids Res. 2025;53(D1):D730\u2013D737.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2738_CR40","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/bioinformatics\/btt138","volume":"29","author":"S Lotia","year":"2013","unstructured":"Lotia S, Montojo J, Dong Y, Bader GD, Pico AR. Cytoscape app store. Bioinformatics. 2013;29(10):1350\u20131.","journal-title":"Bioinformatics"},{"issue":"D1","key":"2738_CR41","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F. TTD: therapeutic target database describing target druggability information. Nucleic Acids Res. 2024;52(D1):D1465\u2013D1477.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2738_CR42","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour SL, Kiwala S, Cotto KC, Coffman AC, McMichael JF, Song JJ, Griffith M, Griffith OL, Wagner AH. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 2021;49(D1):D1144\u2013D1151.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2738_CR43","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, Pon A, Cox J, Chin NEL, Strawbridge SA, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 2024;52(D1):D1265\u2013D1275.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"2738_CR44","doi-asserted-by":"publisher","first-page":"eadd4984","DOI":"10.1126\/sciadv.add4984","volume":"9","author":"AF Schmidt","year":"2023","unstructured":"Schmidt AF, Bourfiss M, Alasiri A, Puyol-Anton E, Chopade S, van Vugt M, van der Laan SW, Gross C, Clarkson C, Henry A, et al. Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity. Sci Adv. 2023;9(17):eadd4984.","journal-title":"Sci Adv"},{"issue":"12","key":"2738_CR45","first-page":"700","volume":"16","author":"GB Lim","year":"2019","unstructured":"Lim GB. Neurohormonal activation in HFpEF. Nat Rev Cardiol. 2019;16(12):700.","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"2738_CR46","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.120.045810","volume":"142","author":"S Sanders-van Wijk","year":"2020","unstructured":"Sanders-van Wijk S, Tromp J, Beussink-Nelson L, Hage C, Svedlund S, Saraste A, Swat SA, Sanchez C, Njoroge J, Tan RS, et al. Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: results from the PROMIS-HFpEF study. Circulation. 2020;142(21):2029\u201344.","journal-title":"Circulation"},{"issue":"18","key":"2738_CR47","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","volume":"118","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023;118(18):3434\u201350.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"2738_CR48","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","volume":"6","author":"N Savji","year":"2018","unstructured":"Savji N, Meijers WC, Bartz TM, Bhambhani V, Cushman M, Nayor M, Kizer JR, Sarma A, Blaha MJ, Gansevoort RT, et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail. 2018;6(8):701\u20139.","journal-title":"JACC Heart Fail"},{"issue":"7","key":"2738_CR49","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.immuni.2023.05.014","volume":"56","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang J, Zheng W, Zhang J, Wang J, Jin T, Tao P, Wang Y, Liu C, Huang J, et al. Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design. Immunity. 2023;56(7):1485-1501.e1487.","journal-title":"Immunity"},{"issue":"6","key":"2738_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109501","volume":"36","author":"D Aguilar-Recarte","year":"2021","unstructured":"Aguilar-Recarte D, Barroso E, Gum\u00e0 A, Pizarro-Delgado J, Pe\u00f1a L, Ruart M, Palomer X, Wahli W, V\u00e1zquez-Carrera M. GDF15 mediates the metabolic effects of PPAR\u03b2\/\u03b4 by activating AMPK. Cell Rep. 2021;36(6):109501.","journal-title":"Cell Rep"},{"issue":"66","key":"2738_CR51","doi-asserted-by":"publisher","first-page":"eabf2489","DOI":"10.1126\/sciimmunol.abf2489","volume":"6","author":"N Niyonzima","year":"2021","unstructured":"Niyonzima N, Rahman J, Kunz N, West EE, Freiwald T, Desai JV, Merle NS, Gidon A, Sporsheim B, Lionakis MS, et al. Mitochondrial C5aR1 activity in macrophages controls IL-1\u03b2 production underlying sterile inflammation. Sci Immunol. 2021;6(66):eabf2489.","journal-title":"Sci Immunol"},{"key":"2738_CR52","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3389\/fimmu.2018.02035","volume":"9","author":"HL Orrem","year":"2018","unstructured":"Orrem HL, Nilsson PH, Pischke SE, Kleveland O, Yndestad A, Ekholt K, Dam\u00e5s JK, Espevik T, Bendz B, Halvorsen B, et al. IL-6 receptor inhibition by tocilizumab attenuated expression of C5a receptor 1 and 2 in non-ST-elevation myocardial infarction. Front Immunol. 2018;9:2035.","journal-title":"Front Immunol"},{"issue":"6","key":"2738_CR53","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1210\/er.2018-00134","volume":"39","author":"E Somm","year":"2018","unstructured":"Somm E, Jornayvaz FR. Fibroblast growth factor 15\/19: from basic functions to therapeutic perspectives. Endocr Rev. 2018;39(6):960\u201389.","journal-title":"Endocr Rev"},{"issue":"1","key":"2738_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bbrc.2018.09.046","volume":"505","author":"W Xu","year":"2018","unstructured":"Xu W, Wang Y, Guo Y, Liu J, Ma L, Cao W, Yu B, Zhou Y. Fibroblast growth factor 19 improves cardiac function and mitochondrial energy homoeostasis in the diabetic heart. Biochem Biophys Res Commun. 2018;505(1):242\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"2738_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.785879","volume":"12","author":"A Dhore-Patil","year":"2021","unstructured":"Dhore-Patil A, Thannoun T, Samson R, Le Jemtel TH. Diabetes mellitus and heart failure with preserved ejection fraction: role of obesity. Front Physiol. 2021;12: 785879.","journal-title":"Front Physiol"},{"issue":"4","key":"2738_CR56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00059-022-05123-9","volume":"47","author":"A Deichl","year":"2022","unstructured":"Deichl A, Wachter R, Edelmann F. Comorbidities in heart failure with preserved ejection fraction. Herz. 2022;47(4):301\u20137.","journal-title":"Herz"},{"issue":"6","key":"2738_CR57","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/cvr\/cvab197","volume":"118","author":"L Rouhi","year":"2022","unstructured":"Rouhi L, Fan S, Cheedipudi SM, Braza-Bo\u00efls A, Molina MS, Yao Y, Robertson MJ, Coarfa C, Gimeno JR, Molina P, et al. The EP300\/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure. Cardiovasc Res. 2022;118(6):1466\u201378.","journal-title":"Cardiovasc Res"},{"key":"2738_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155659","volume":"130","author":"T Fang","year":"2024","unstructured":"Fang T, Wang J, Sun S, Deng X, Xue M, Han F, Sun B, Chen L. JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53. Phytomedicine. 2024;130: 155659.","journal-title":"Phytomedicine"},{"issue":"1","key":"2738_CR59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40618-024-02419-x","volume":"48","author":"PJ Giraudi","year":"2025","unstructured":"Giraudi PJ, Pascut D, Banfi C, Ghilardi S, Tiribelli C, Bondesan A, Caroli D, Minocci A, Sartorio A. Serum proteome signatures associated with liver steatosis in adolescents with obesity. J Endocrinol Invest. 2025;48(1):213\u201325.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2738_CR60","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.3390\/ijms24032988","volume":"24","author":"M Szlagor","year":"2023","unstructured":"Szlagor M, Dybiec J, M\u0142ynarska E, Rysz J, Franczyk B. Chronic kidney disease as a comorbidity in heart failure. Int J Mol Sci. 2023;24(3):2988.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2738_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295532","volume":"18","author":"J Zhang","year":"2023","unstructured":"Zhang J, Hu Z, Tan Y, Ye J. Causal relationship from heart failure to kidney function and CKD: a bidirectional two-sample mendelian randomization study. PLoS ONE. 2023;18(12): e0295532.","journal-title":"PLoS ONE"},{"key":"2738_CR62","doi-asserted-by":"publisher","first-page":"1190938","DOI":"10.3389\/fimmu.2023.1190938","volume":"14","author":"C Hu","year":"2023","unstructured":"Hu C, Li Y, Qian Y, Wu Z, Hu B, Peng Z. Kidney function and cardiovascular diseases: a large-scale observational and Mendelian randomization study. Front Immunol. 2023;14:1190938.","journal-title":"Front Immunol"},{"issue":"7","key":"2738_CR63","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/CIRCULATIONAHA.118.038602","volume":"139","author":"IR Mordi","year":"2019","unstructured":"Mordi IR, Pearson ER, Palmer CNA, Doney ASF, Lang CC. Differential association of genetic risk of coronary artery disease with development of heart failure with reduced versus preserved ejection fraction. Circulation. 2019;139(7):986\u20138.","journal-title":"Circulation"},{"issue":"2","key":"2738_CR64","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, Preall J, Tuveson DA. IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 2019;9(2):282\u2013301.","journal-title":"Cancer Discov"},{"issue":"3","key":"2738_CR65","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.stem.2020.06.020","volume":"27","author":"J Choi","year":"2020","unstructured":"Choi J, Park JE, Tsagkogeorga G, Yanagita M, Koo BK, Han N, Lee JH. Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration. Cell Stem Cell. 2020;27(3):366-382.e367.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2738_CR66","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12916-022-02650-4","volume":"20","author":"A van Ommen","year":"2022","unstructured":"van Ommen A, Canto ED, Cramer MJ, Rutten FH, Onland-Moret NC, Ruijter HMD. Diastolic dysfunction and sex-specific progression to HFpEF: current gaps in knowledge and future directions. BMC Med. 2022;20(1):496.","journal-title":"BMC Med"},{"issue":"8","key":"2738_CR67","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/ejhf.2563","volume":"24","author":"H Sorimachi","year":"2022","unstructured":"Sorimachi H, Omote K, Omar M, Popovic D, Verbrugge FH, Reddy YNV, Lin G, Obokata M, Miles JM, Jensen MD, et al. Sex and central obesity in heart failure with preserved ejection fraction. Eur J Heart Fail. 2022;24(8):1359\u201370.","journal-title":"Eur J Heart Fail"},{"issue":"47","key":"2738_CR68","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","volume":"40","author":"CSP Lam","year":"2019","unstructured":"Lam CSP, Arnott C, Beale AL, Chandramouli C, Hilfiker-Kleiner D, Kaye DM, Ky B, Santema BT, Sliwa K, Voors AA. Sex differences in heart failure. Eur Heart J. 2019;40(47):3859\u20133868c.","journal-title":"Eur Heart J"},{"issue":"1","key":"2738_CR69","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","volume":"139","author":"Y Cai","year":"2019","unstructured":"Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang Y, Fleming C, Hu X, Zhang HG, Weichselbaum R, et al. A critical role of the IL-1\u03b2-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J Invest Dermatol. 2019;139(1):146\u201356.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2738_CR70","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13075-016-1212-x","volume":"19","author":"AH Brachat","year":"2017","unstructured":"Brachat AH, Grom AA, Wulffraat N, Brunner HI, Quartier P, Brik R, McCann L, Ozdogan H, Rutkowska-Sak L, Schneider R, et al. Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy. Arthritis Res Ther. 2017;19(1):13.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"2738_CR71","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/art.41640","volume":"73","author":"EL Verweyen","year":"2021","unstructured":"Verweyen EL, Pickering A, Grom AA, Schulert GS. Distinct gene expression signatures characterize strong clinical responders versus nonresponders to canakinumab in children with systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2021;73(7):1334\u201340.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"2738_CR72","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/gutjnl-2020-321731","volume":"70","author":"D Aschenbrenner","year":"2021","unstructured":"Aschenbrenner D, Quaranta M, Banerjee S, Ilott N, Jansen J, Steere B, Chen YH, Ho S, Cox K, Arancibia-C\u00e1rcamo CV, et al. Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut. 2021;70(6):1023\u201336.","journal-title":"Gut"},{"key":"2738_CR73","doi-asserted-by":"publisher","first-page":"1339337","DOI":"10.3389\/fimmu.2023.1339337","volume":"14","author":"JL Sanz-Cabanillas","year":"2023","unstructured":"Sanz-Cabanillas JL, G\u00f3mez-Garc\u00eda F, G\u00f3mez-Arias PJ, Montilla-L\u00f3pez A, Gay-Mimbrera J, Ruano J, Isla-Tejera B, Parra-Peralbo E. Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review. Front Immunol. 2023;14:1339337.","journal-title":"Front Immunol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02738-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02738-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02738-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T11:04:14Z","timestamp":1747047854000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02738-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2738"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02738-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Summary-level GWAS statistics used in this study is publicly available and no specific ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}